Detalhe da pesquisa
1.
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients.
Br J Haematol
; 202(5): 953-959, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37357817
2.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Br J Haematol
; 203(3): 416-425, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37580908
3.
Sialylation regulates migration in chronic lymphocytic leukemia.
Haematologica
; 108(7): 1851-1860, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36779594
4.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36632738
5.
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.
Hematol Oncol
; 41(3): 343-353, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36521843
6.
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Hematol Oncol
; 41(1): 50-60, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36251440
7.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33378569
8.
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.
Br J Haematol
; 188(2): 249-258, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31385309
9.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol
; 189(5): 853-859, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32064595
10.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32816326
11.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Br J Cancer
; 121(2): 150-156, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31209327
12.
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Br J Haematol
; 184(3): 392-396, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30338509
13.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31325190
14.
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
Br J Haematol
; 201(2): 353-356, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36793194
15.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Blood
; 138(25): 2727-2730, 2021 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34587233
16.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36190298
17.
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
Br J Haematol
; 177(4): 588-596, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28419517
18.
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
Br J Haematol
; 198(2): e28-e31, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35499213
19.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26276669
20.
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia.
Haematologica
; 107(1): 334-337, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34647439